11/04/2024
3:40 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
3:42 PM | Aquestive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/25/2024
7:05 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
7:06 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
5:06 PM | Aquestive Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
10/16/2024
4:16 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
1:14 PM | Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
| Form 4/A | |
|
10/02/2024
1:15 PM | Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
| Form 4/A | |
10/02/2024
1:15 PM | Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
| Form 4/A | |
10/02/2024
1:16 PM | Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
| Form 4/A | |
09/27/2024
7:46 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
7:56 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:08 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
1:45 PM | Aquestive Therapeutics (Issuer)
Kraus Carl N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:26 PM | Aquestive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/25/2024
7:16 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
3:32 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
12:51 PM | Aquestive Therapeutics (Issuer)
MORRIS TIMOTHY E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
12:50 PM | Aquestive Therapeutics (Issuer)
COSTA SANTO J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
12:50 PM | Aquestive Therapeutics (Issuer)
Cochran John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
12:50 PM | Aquestive Therapeutics (Issuer)
Krop Julie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
12:51 PM | Aquestive Therapeutics (Issuer)
BROWN GREGORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
12:51 PM | Aquestive Therapeutics (Issuer)
Taglietti Marco (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
4:14 PM | Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
| Form 3/A | |
06/11/2024
11:35 AM | Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/11/2024
11:36 AM | Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:13 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
12:40 PM | Aquestive Therapeutics (Issuer)
Jenkins Abigail L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
12:40 PM | Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
8:08 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:21 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:23 PM | Aquestive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
8:30 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
8:20 AM | Aquestive Therapeutics (Issuer)
Jenkins Abigail L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/24/2024
5:23 AM | Aquestive Therapeutics (Filer)
Aquestive Therapeutics (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
04/24/2024
5:25 AM | Aquestive Therapeutics (Filer)
Aquestive Therapeutics (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
04/23/2024
11:15 PM | Aquestive Therapeutics (Filer)
| Form EFFECT | |
04/03/2024
4:27 PM | Aquestive Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/01/2024
5:21 PM | Aquestive Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G | |
04/01/2024
7:15 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
1:30 PM | Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
There is a little known company that is changing warfare (Ad) With geo - political instability around the world investors are flocking to defense contract stocks.
There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military. Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t |
03/14/2024
8:56 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
12:45 PM | Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:46 PM | Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:46 PM | Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:47 PM | Aquestive Therapeutics (Issuer)
TOTH A ERNEST JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:47 PM | Aquestive Therapeutics (Issuer)
BRAENDER LORI J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:47 PM | Aquestive Therapeutics (Issuer)
Boyd Peter E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
12:47 PM | Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:34 AM | Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:35 AM | Aquestive Therapeutics (Issuer)
Boyd Peter E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:35 AM | Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:35 AM | Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:35 AM | Aquestive Therapeutics (Issuer)
Kraus Carl N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:36 AM | Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:36 AM | Aquestive Therapeutics (Issuer)
TOTH A ERNEST JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
9:36 AM | Aquestive Therapeutics (Issuer)
BRAENDER LORI J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:09 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
4:12 PM | Aquestive Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
2:24 PM | Aquestive Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G | |
12/08/2023
9:46 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
7:51 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
